Company intelligence / Profile preview

Viola

Ukraine

Ownership: Private
Development stage: Other

Overview

Viola is among the top 10 domestic pharmaceutical manufacturers in Ukraine, producing over 400+ medicines and parapharmaceuticals under certified GMP and ISO standards. The company is rapidly expanding its R&D laboratory and pipeline, focusing on modern generic drugs and complex treatment approaches. Viola's product portfolio includes pain relievers, topical antifungals, antiseptics, and supplements, with an active program for bringing new generics and medicinal forms to market.

Modalities: Small moleculeBiologic
Industry: Biotech

Drug pipeline

5 assets

Pertusin

4 more assets in the full pipeline.

Request access →

Partnerships

Genom

Beyond the preview

Go deeper on Viola.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viola.

Explore the full profile